RecruitingNCT07149688

Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study

Sponsor

Beijing Anzhen Hospital

Enrollment

30,000 participants

Start Date

Mar 1, 2024

Study Type

OBSERVATIONAL

Conditions

Heart Failure Hypertension Coronary Heart Disease (CHD)Atrial Fibrillation (AF)

Summary

This is a prospective observational cohort study conducted in Qujiang District, Zhejiang Province, China, aiming to evaluate the effectiveness of a comprehensive management program for elderly patients with chronic cardiovascular diseases (CVDs). The program integrates pharmacological treatment, lifestyle modification, health education, and long-term follow-up, with enhanced monitoring using 7-day ECG recording. The study focuses on major chronic CVDs including hypertension, coronary artery disease, atrial fibrillation, and heart failure. Approximately 30,000 participants aged ≥60 years will be enrolled and followed for up to 10 years.

Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This is a long-term observational study (registry) following elderly residents of the Qujiang District in China who have chronic cardiovascular disease. Researchers want to understand how these conditions are managed and how patients fare over time in a village-based healthcare setting. **You may be eligible if...** - You are 60 years old or older - You live in the Qujiang District - You have been diagnosed with a chronic cardiovascular condition such as high blood pressure, coronary artery disease, heart failure, or atrial fibrillation - You are willing and able to provide informed consent **You may NOT be eligible if...** - You have severe cognitive impairment or are unable to provide consent - Your life expectancy is less than 1 year due to a non-cardiovascular illness - You do not wish to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEComprehensive management program (pharmacologic treatment, lifestyle modification, health education, structured follow-up)

Comprehensive management program (pharmacologic treatment, lifestyle modification, health education, structured follow-up) Enhanced monitoring with 7-day ECG

Locations(1)

Beijing Anzhen Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07149688

Related Trials

Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.

NCT037624991 location

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT070644731152 locations